AVALYN PHARMACEUTICALS INC COM SHS

AVALYN PHARMACEUTICALS INC COM SHS is a security (CUSIP 05348Y105) tracked across SEC portfolio filings. 11 institutional managers reported $64.8M on Form 13F as of 2026-06-30; 4 registered fund positions totaling $17.7M via N-PORT as of 2026-05-31.

Summary

Top institutional holders (Form 13F)

ManagerLocationValueShares
ANDERA PARTNERSPARIS, I0$30.6M929,824
JENNISON ASSOCIATES LLCNEW YORK, NY$26.8M812,749
TD Asset Management IncToronto, A6$3.1M94,636
Aberdeen Group plcEDINBURGH, X0$2.2M67,174
Bank of New York Mellon CorpNEW YORK, NY$1.3M40,140
CITIGROUP INCNEW YORK, NY$265K8,035
NEW YORK STATE COMMON RETIREMENT FUNDALBANY, NY$198K6,000
Police & Firemen's Retirement System of New JerseyTRENTON, NJ$166K5,052
STRS OHIOCOLUMBUS, OH$112K3,400
Russell Investments Group, Ltd.Seattle, WA$45K1,369
Sterling Capital Management LLCCHARLOTTE, NC$5K149

Top fund holders (N-PORT)

FundRegistrantValue% of fund
PGIM Jennison Health Sciences FundPrudential Sector Funds, Inc.$9.2M66.01%
Fidelity Growth Company FundFidelity Mt. Vernon Street Trust$7.7M0.78%
VANGUARD RUSSELL 2000 INDEX FUNDVANGUARD SCOTTSDALE FUNDS$456K0.26%
T. Rowe Price Spectrum Moderate Growth Allocation FundT. ROWE PRICE SPECTRUM FUNDS II, INC.$396K0.92%

More